Deepak Chadha - Net Worth and Insider Trading
Deepak Chadha Net Worth
The estimated net worth of Deepak Chadha is at least $1,285 dollars as of 2024-11-13. Deepak Chadha is the Chief Research & Dev. Officer of Fresh Tracks Therapeutics Inc and owns about 1,737 shares of Fresh Tracks Therapeutics Inc (FRTX) stock worth over $1,285. Details can be seen in Deepak Chadha's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Deepak Chadha has not made any transactions after 2021-05-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Deepak Chadha
Deepak Chadha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Deepak Chadha owns 1 companies in total, including Fresh Tracks Therapeutics Inc (FRTX) .
Click here to see the complete history of Deepak Chadha’s form 4 insider trades.
Insider Ownership Summary of Deepak Chadha
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2021-06-14 | Chief Research & Dev. Officer |
Deepak Chadha Latest Holdings Summary
Deepak Chadha currently owns a total of 1 stock. Deepak Chadha owns 1,737 shares of Fresh Tracks Therapeutics Inc (FRTX) as of May 19, 2021, with a value of $1,285.
Latest Holdings of Deepak Chadha
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics Inc | 2021-05-19 | 1,737 | 0.74 | 1,285 |
Holding Weightings of Deepak Chadha
Deepak Chadha Form 4 Trading Tracker
According to the SEC Form 4 filings, Deepak Chadha has made a total of 1 transactions in Fresh Tracks Therapeutics Inc (FRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fresh Tracks Therapeutics Inc is the acquisition of 338 shares on May 19, 2021, which cost Deepak Chadha around $12,616.
Insider Trading History of Deepak Chadha
- 1
Deepak Chadha Trading Performance
GuruFocus tracks the stock performance after each of Deepak Chadha's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Deepak Chadha is -27.09%. GuruFocus also compares Deepak Chadha's trading performance to market benchmark return within the same time period. The performance of stocks bought by Deepak Chadha within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Deepak Chadha's insider trading performs compared to the benchmark.
Performance of Deepak Chadha
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.47 | | | | | |
| Relative Return to S&P 500(%) | -3.7 | | | | | |
Deepak Chadha Ownership Network
Ownership Network List of Deepak Chadha
Ownership Network Relation of Deepak Chadha
Deepak Chadha Owned Company Details
What does Fresh Tracks Therapeutics Inc do?
Who are the key executives at Fresh Tracks Therapeutics Inc?
Deepak Chadha is the Chief Research & Dev. Officer of Fresh Tracks Therapeutics Inc. Other key executives at Fresh Tracks Therapeutics Inc include Chief Medical Officer Monica E. Luchi , director & CHAIRMAN OF THE BOARD Reginald L Hardy , and General Counsel and CCO David R. Mcavoy .
Fresh Tracks Therapeutics Inc (FRTX) Insider Trades Summary
Over the past 18 months, Deepak Chadha made no insider transaction in Fresh Tracks Therapeutics Inc (FRTX). Other recent insider transactions involving Fresh Tracks Therapeutics Inc (FRTX) include a net sale of 110 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Fresh Tracks Therapeutics Inc (FRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 110 shares of Fresh Tracks Therapeutics Inc (FRTX) were sold and 1,086,412 shares were bought by its insiders, resulting in a net purchase of 1,086,302 shares.
Fresh Tracks Therapeutics Inc (FRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fresh Tracks Therapeutics Inc Insider Transactions
Deepak Chadha Mailing Address
Above is the net worth, insider trading, and ownership report for Deepak Chadha. You might contact Deepak Chadha via mailing address: 5777 Central Avenue, Suite 102, Boulder Co 80301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
